SUPAC-IR: Immediate-Release Solid Oral Dosage Forms: Scale-Up and Post-Approval Changes: Chemistry, Manufacturing and Controls, In Vitro Dissolution Testing, and In Vivo Bioequivalence Documentation
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 1, 1995
May 5, 2020
d92f2615-a9dd-43a1-bed0-97946ea41dbf
Related Documents
SUPAC-SS: Nonsterile Semisolid Dosage Forms; Scale-Up and Post-Approval Changes: Chemistry, Manufacturing and Controls; In Vitro Release Testing and In Vivo Bioequivalence Documentation: Guidance for Industry
Guidance DocumentMay 1, 1997Center for Drug Evaluation and Research
SUPAC-MR: Modified Release Solid Oral Dosage Forms Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation: Guidance for Industry
Guidance DocumentOctober 6, 1997Center for Drug Evaluation and Research
Dissolution Testing of Immediate Release Solid Oral Dosage Forms
Guidance DocumentAugust 25, 1997Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox